1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

EMBO elects 56 new Members


Heidelberg, 11 June 2019 – EMBO announces today that 56 life scientists have been elected to its membership, joining a group of more than 1800 of the best researchers in Europe and around the world.


“EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution,” says EMBO Director Maria Leptin.


EMBO Members actively participate in the execution of the organization’s initiatives by serving on Council, committees and editorial boards, by evaluating applications for EMBO funding, by mentoring young scientists and by providing suggestions and feedback on activities.


The 48 new EMBO Members reside in 17 Member States of the European Molecular Biology Conference (EMBC), EMBO’s intergovernmental funding body. The 8 new EMBO Associate Members are researchers currently working in Argentina, Australia, Japan, Singapore and the USA.


Ever since the very first EMBO Council, chaired by Max Perutz, was tasked with selecting and inviting the initial EMBO Members in 1963, new members are nominated and elected by the existing membership. This year, participation in the election process was especially high, with 65% of the eligible existing EMBO Members taking part.


EMBO will formally welcome its new Members and Associate Members at the annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.


An online directory listing all EMBO Members, their affiliations and areas of expertise is available at people.embo.org.



Selected statistics:

  • 48 Members and 8 Associate Members were elected
  • newly elected Members reside in 22 countries
  • 24 new EMBO members (42.9%) are women


New EMBO Members 2019


Andrea Ablasser

Swiss Federal Institute of Technology (EPFL), Lausanne, CH

Sonja-Verena Albers

Universität Freiburg, DE

Roberto Bassi

Università degli Studi, Verona, IT

Peter Baumann

Institute of Molecular Biology (IMB) and Johannes Gutenberg University, Mainz, DE

Richard Benton

University of Lausanne, CH

Judith Berman

Tel Aviv University, IL 

Melanie Blokesch

Swiss Federal Institute of Technology (EPFL), Lausanne, CH

Wout Boerjan

VIB-UGent Center for Plant Systems Biology, Gent, BE

Alain Chédotal

Institut de la Vision, Paris, FR

Peter R. Cook

University of Oxford, UK

Nynke H. Dekker

Kavli Institute of Nanoscience Delft, Delft University of Technology, NL 

Andrzej Dziembowski

The Polish Academy of Sciences, Warsaw, PL

I. Sadaf Farooqi

University of Cambridge, UK

George A. Garinis

University of Crete and IMBB - FORTH, Heraklion, GR 

Fanni Gergely

Cancer Research UK Cambridge Institute, University of Cambridge, UK

José Luis Gómez-Skarmeta

Centro Andaluz de Biología del Desarrollo, CSIC / Universidad Pablo de Olavide, Sevilla, ES

Thomas Gregor

Institut Pasteur, Paris, FR and Princeton University, US

Barbara Ann Halkier

University of Copenhagen, DK 

Birgitta Henriques Normark

Karolinska Institutet, Stockholm, SE

Elina Ikonen

University of Helsinki, FI

Sten Eirik W. Jacobsen

Karolinska Institutet, Stockholm, SE, and University of Oxford, UK

Peter Jonas

Institute of Science and Technology Austria (IST), Klosterneuburg, AT 

Paul Lehner

University of Cambridge, UK 

Ruth E. Ley

MPI für Entwicklungsbiologie, Tübingen, DE

Purificación López-García

CNRS / Université Paris-Sud, Orsay, FR

Susan E. Mango

University of Basel, CH

Giovanni Marsicano

NeuroCentre Magendie, U1215 INSERM and University of Bordeaux, FR

Adèle L. Marston

Wellcome Centre for Cell Biology, Edinburgh, UK

Roberto Mayor

University College London, UK

Ron Milo

Weizmann Institute of Science, Rehovot, IL 

Garib Murshudov

MRC Laboratory of Molecular Biology, Cambridge, UK 

Marcin Nowotny

International Institute of Molecular and Cell Biology, Warsaw, PL

Lalita Ramakrishnan

MRC LMB / University of Cambridge, UK 

Katrin Rittinger

Francis Crick Institute, London, UK 

Aurélien Roux

University of Geneva, CH

Rickard Sandberg

Karolinska Institutet, Stockholm, SE 

James Sharpe

EMBL Barcelona, ES

Bruno Silva-Santos

Instituto de Medicina Molecular João Lobo Antunes, Lisbon, PT

Nicole Soranzo

Wellcome Sanger Institute and University of Cambridge, UK

Robert Tampé

Biocenter, Goethe University, Frankfurt, DE

Manuel Théry

CEA at Hôpital St. Louis, Paris, FR 

Miguel Torres

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, ES

James M. Turner

Francis Crick Institute, London, UK

Štěpánka Vaňáčová

Central European Institute of Technology (CEITEC), Masaryk University, Brno, CZ

Éric Vivier

Centre d’Immunologie de Marseille Luminy, FR and Innate Pharma, Marseille, FR

Julia Vorholt

ETH Zurich, CH 

Patrick Wincker

Genoscope, Evry, FR

Claire Wyart

Institut du Cerveau et de la Moelle épinière (ICM), Paris, FR 



New EMBO Associate Members 2019


Frédéric J. de Sauvage

Genentech, South San Francisco, US

Yoshihide Hayashizaki

RIKEN Preventive Medicine & Diagnosis Innovation Program, Saitama, JP

Eva Nogales

HHMI, University of California and Lawrence Berkeley National Laboratory, Berkeley, US

Noriko Osumi

Tohoku University, Sendai, JP

Fernando J. Pitossi

Fundación Instituto Leloir – CONICET, Buenos Aires, AR

G.V. Shivashankar

National University of Singapore, SG

Jennifer L. Stow

University of Queensland, Brisbane, AU

Joanna Wysocka

Stanford University, US


This email address is being protected from spambots. You need JavaScript enabled to view it.


Tilmann KießlingTilmann Kießling
Head, Communications
T. + 49 160 9019 3839